CLX vs SYRE · P/E 15, rev $7.10B vs $7.60B cap
The Clorox Company (CLX) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the CLX and SYRE stock pages for the full models.
Not investment advice.